P.259 Retreatment with peginterferon alpha-2a (40KD) (Pegasys®) plus ribavirin (Copegus®) in patients in whom pegylated interferon alpha-2b (12KD)/ribavirin has failed: planned week-12 efficacy and safety analysis of the repeat study

Autor:	Carlos E. Brandao-Mello, Pietro Andreone, G. Teuber, Patrick Marcellin, O. Weiland, V. Canva, A. Di Bisceglie, Donald M. Jensen, R. Rai, B. Freilich
Rok vydání:	2006
Předmět:	medicine.medical_specialty business.industry Ribavirin Pegylated interferon alpha-2b Peginterferon alpha-2a Gastroenterology chemistry.chemical_compound Infectious Diseases chemistry Virology Internal medicine medicine In patient business
Zdroj:	Journal of Clinical Virology. 36:S142
ISSN:	1386-6532
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::9fe4d9bd5c1ee0fd02badf2699bf4fb5 https://doi.org/10.1016/s1386-6532(06)80439-7 Zobrazit plný text záznamu Full Text from ScienceDirect